A third of refractory patients respond to trastuzumab-DM1: Commentary

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalOncology Report
Issue numberJANUARY-FEBRUARY
StatePublished - Mar 15 2010

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this